LUMC is a modern university medical center for research, education and patient care with a high quality profile and a strong scientific orientation. The LUMC has set Regenerative Medicine as one of its key focus areas.
CCRM is a not-for-profit, public-private consortium supporting the development of foundational technologies that accelerate the commercialization of cell and gene therapies, and regenerative medicine technologies.
Starfish Innovations brings new medicines closer to the patient by commercialising innovative regenerative medicine therapies, diagnostics and technologies from leading European universities, Institutes and other partners to accelerate breakthroughs in regenerative medicine across a broad range of diseases.
The university is founded in 1575 and has seven academic faculties and over fifty subject departments while housing more than 40 national and international research institutes.
The Centre for Human Drug Research (CHDR) is an independent institute that specialises in cutting-edge early-stage clinical drug research.
RegMed XB is a virtual institute of Dutch and Belgian public (universities and governments) and private (health foundations and companies) partners that will work together to develop regenerative medicine solutions to health challenges.